We offer patients with pancreatic cancer access to promising new therapies available through clinical trials. We inform patients about any clinical trials for which they may be eligible and educate patients and families about all aspects of participation in a clinical trial.
The Institute for Hepatobiliary and Pancreatic Surgery/BIDMC is now a full member of the
Pancreas Cancer Research Team (PCRT), the preeminent clinical trials network in the world for innovative human studies in pancreatic cancer. A "Stand Up To Cancer" grant awardee, PCRT is currently engaged in 14 trials, with four new trials pending, offering patients access to the most promising new agents against pancreatic cancer. BIDMC is now the largest PCRT center in New England and the only Dana-Farber/Harvard Cancer Center member to be affiliated with the network.
For general information about participating in a clinical trial, click
For information about clinical trials that are enrolling Institute of Hepatobiliary and Pancreatic Surgery patients, please speak with your doctor, call our main number (in the box at right), or e-mail